Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
6160.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
N/A
-28.54
vs -3.35
Q3.23
N/A
-1.20
vs -3.25
Q4.23
N/A
-0.27
vs -0.33
Q1.24
N/A
-1.45
vs -2.02
Q2.24
N/A
-0.69
vs -28.54
Q3.24
N/A
-0.69
vs -1.20
Q4.24
N/A
-0.85
vs -0.27
Q1.25
+100%
0.01
vs -1.45
Q2.25
+103%
0.02
vs -0.69
Q3.25
+104%
0.03
vs -0.69
Sales Growth
YoY
Current
Estimates
Q2.23
+74%
595.3M vs 341.6M
Q3.23
+102%
781.3M vs 387.6M
Q4.23
+67%
634.4M vs 380.1M
Q1.24
+68%
751.7M vs 447.8M
Q2.24
+56%
929.2M vs 595.3M
Q3.24
+28%
1B vs 781.3M
Q4.24
+78%
1.1B vs 634.4M
Q1.25
+49%
1.1B vs 751.7M
Q2.25
+31%
1.2B vs 929.2M
Q3.25
+30%
1.3B vs 1B
Return on Equity
QoQ
Q2.23
-10%
-0.10
vs -0.08
Q3.23
+6%
0.06
vs -0.10
Q4.23
-75%
-0.75
vs 0.06
Q1.24
-7%
-0.07
vs -0.75
Q2.24
-4%
-0.04
vs -0.07
Q3.24
-4%
-0.04
vs -0.04
Q4.24
-5%
-0.05
vs -0.04
Q1.25
+0%
0
vs -0.05
Institutionnal Ownership
QoQ
Q1.23
1
1
vs NA
NA
Q2.23
1
1
vs 1
NA
Q3.23
1
1
vs 1
NA
Q4.23
1
1
vs 1
NA
Q1.24
1
1
vs 1
NA
Q2.24
1
1
vs 1
NA
Q4.24
1
1
vs NA
NA
Relative Strength
6160.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
HKSE
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.80Â ( -0.54%)
Relative Strenght
Volume Buzz
-43%
Earning Acce
No
Dist 52w H.
17%Quote Panel
Key Metrics
Forecast
455%2026-Revenue
48182%2026-EPS
-10150%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 6160.HK compares to sector?